Vimarsana
Biggest News Aggregation in the World

Page 17 - Cell Cycle News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Cycle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Cycle Today - Breaking & Trending Today

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor - Vimarsana News

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

The role played by the host enzyme TMPRSS2 in infection and cancer is the focus of a new study.

RGCC/RGC-32, a Cell Cycle Protein Regulator, Protects Against Pulmonary Fibrosis - Vimarsana News

RGCC/RGC-32, a Cell Cycle Protein Regulator, Protects Against Pulmonary Fibrosis

Previous research in tissue fibrosis has revealed the expression of a protein called either Regulator of Cell Cycle (RGCC) or Response Gene to Complement 32 Protein plays a profibrotic role (RGC-32). In contrast, the examination of publicly available gene expression datasets demonstrated a consistent drop in RGCC mRNA levels in people with pulmonary fibrosis. Researchers

Related Topics:
Cell CycleResponse Gene
Arvinas and Pfizer Announce PROTAC Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer - Vimarsana News

Arvinas and Pfizer Announce PROTAC Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer

10.12.2021 - – ARV-471 continues to show a favorable tolerability profile and robust ER degradation in updated phase 1 dose escalation data presented at San Antonio Breast Cancer Symposium – – ARV-471 is expected to enter two Phase 3 registrational clinical ...

Potential association between senescence and aging in COVID-19 - Vimarsana News

Potential association between senescence and aging in COVID-19

A review published in Cells discussed characteristics of cellular senescence and its potential role in COVID-19.

TPGS2000-DOX prodrug micelles for improving BC therapy - Vimarsana News

TPGS2000-DOX prodrug micelles for improving BC therapy

TPGS2000-DOX prodrug micelles reverse the MDR of tumor cells, achieve passive targeting by forming nanomicelles, & enhance the efficacy & reduce DOC toxicity.